Johannes TACK,Christoph VOELKEL,Reinhard HOROWSKI,Matthias BRAEUTIGAM,Dirk PALLA
申请号：
US16337521
公开号：
US20190224153A1
申请日:
2017.09.29
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention describes a new method and new combination products for the therapy of neurological and other conditions which respond to dopaminergic therapies and especially to L-DOPA (L-Dihydroxy-Phenylalanine) based on the use of L-DOPA esters, especially of L-DOPA glycerol ester and L-DOPA Cholin Ester.
